CHAMPIONS ONCOLOGY, INC. Warrants Not Settleable in Cash, Fair Value Disclosure
CHAMPIONS ONCOLOGY, INC. (CSBR) had Warrants Not Settleable in Cash, Fair Value Disclosure of $600.00 thousand as of 2015-01-31, per its 10-Q filed 2015-03-17.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:WarrantsNotSettleableInCashFairValueDisclosure · last filed 2015-03-17
- 2015-01-31: Warrants Not Settleable in Cash, Fair Value Disclosure $600.00K.
- 2014-10-31: Warrants Not Settleable in Cash, Fair Value Disclosure $1.23M.
- 2014-07-31: Warrants Not Settleable in Cash, Fair Value Disclosure $1.86M.
- 2014-04-30: Warrants Not Settleable in Cash, Fair Value Disclosure $2.01M.
| Period end | Warrants Not Settleable in Cash, Fair Value Disclosure |
|---|---|
| 2015-01-31 | $600.00K 10-Q · filed 2015-03-17 |
| 2014-10-31 | $1.23M 10-Q · filed 2014-12-15 |
| 2014-07-31 | $1.86M 10-Q · filed 2014-09-12 |
| 2014-04-30 | $2.01M 10-Q · filed 2015-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |